DK1063294T3 - DNA'er eller gener der deltager i Parkinsons sygdom - Google Patents
DNA'er eller gener der deltager i Parkinsons sygdomInfo
- Publication number
- DK1063294T3 DK1063294T3 DK99902859T DK99902859T DK1063294T3 DK 1063294 T3 DK1063294 T3 DK 1063294T3 DK 99902859 T DK99902859 T DK 99902859T DK 99902859 T DK99902859 T DK 99902859T DK 1063294 T3 DK1063294 T3 DK 1063294T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- parkinson
- dnas
- genes involved
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2753198 | 1998-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1063294T3 true DK1063294T3 (da) | 2006-05-22 |
Family
ID=12223704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99902859T DK1063294T3 (da) | 1998-02-09 | 1999-02-09 | DNA'er eller gener der deltager i Parkinsons sygdom |
Country Status (10)
Country | Link |
---|---|
US (2) | US6716621B1 (fr) |
EP (1) | EP1063294B1 (fr) |
JP (1) | JP4430815B2 (fr) |
AT (1) | ATE315645T1 (fr) |
AU (1) | AU2299999A (fr) |
CA (1) | CA2320220C (fr) |
DE (2) | DE1063294T1 (fr) |
DK (1) | DK1063294T3 (fr) |
ES (1) | ES2257029T3 (fr) |
WO (1) | WO1999040191A1 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2775984B1 (fr) * | 1998-03-11 | 2006-09-15 | Bioscreen Therapeutics Sa | Criblage differentiel qualitatif |
ATE315645T1 (de) * | 1998-02-09 | 2006-02-15 | Boehringer Ingelheim Int | Dns oder gene, die an der parkinsonschen krankheit beteiligt sind |
DK1131424T3 (da) * | 1998-11-19 | 2009-11-23 | Aventis Pharma Sa | Mutationer af Pakin-genet, sammensætninger, fremgangsmåder samt anvendelser |
CA2996759A1 (fr) | 1998-11-19 | 2000-06-02 | Aventis Pharma S.A. | Mutations du gene de la parkine, compositions, methodes et utilisations |
EP1081225A1 (fr) * | 1999-08-30 | 2001-03-07 | Biofrontera Pharmaceuticals GmbH | Modèle animal transgénique de maladies neurodégénératives |
EP1262557B1 (fr) * | 2000-02-24 | 2006-10-18 | Boehringer Ingelheim International GmbH | Proteine parkine utilisee comme ubiquitine ligase |
AU2001260140A1 (en) | 2000-03-22 | 2001-10-03 | Avntis Pharma Deutschland Gmbh | Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene. |
US7070940B2 (en) * | 2002-07-18 | 2006-07-04 | Aventis Pharma S.A. | Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein |
US8506959B2 (en) | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US8697082B2 (en) | 2002-11-01 | 2014-04-15 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US20080014194A1 (en) | 2003-10-31 | 2008-01-17 | Elan Pharmaceuticals, Inc. | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
US9034337B2 (en) | 2003-10-31 | 2015-05-19 | Prothena Biosciences Limited | Treatment and delay of outset of synucleinopathic and amyloidogenic disease |
TW200509968A (en) | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
US7358331B2 (en) | 2003-05-19 | 2008-04-15 | Elan Pharmaceuticals, Inc. | Truncated fragments of alpha-synuclein in Lewy body disease |
US7674599B2 (en) | 2003-11-08 | 2010-03-09 | Elan Pharmaceuticals, Inc. | Methods of using antibodies to detect alpha-synuclein in fluid samples |
JP5329434B2 (ja) | 2007-01-31 | 2013-10-30 | エラン・フアルマ・インターナシヨナル・リミテツド | 新規基質を使用したパーキン活性のモジュレーターのアッセイ方法 |
US8147833B2 (en) | 2007-02-23 | 2012-04-03 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
EP2118300B1 (fr) | 2007-02-23 | 2015-05-27 | Prothena Biosciences Limited | Prévention et traitement de maladies synucléinopathiques et amyloïdogéniques |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE315645T1 (de) * | 1998-02-09 | 2006-02-15 | Boehringer Ingelheim Int | Dns oder gene, die an der parkinsonschen krankheit beteiligt sind |
-
1999
- 1999-02-09 AT AT99902859T patent/ATE315645T1/de active
- 1999-02-09 AU AU22999/99A patent/AU2299999A/en not_active Abandoned
- 1999-02-09 CA CA2320220A patent/CA2320220C/fr not_active Expired - Fee Related
- 1999-02-09 US US09/601,844 patent/US6716621B1/en not_active Expired - Fee Related
- 1999-02-09 DK DK99902859T patent/DK1063294T3/da active
- 1999-02-09 ES ES99902859T patent/ES2257029T3/es not_active Expired - Lifetime
- 1999-02-09 DE DE1063294T patent/DE1063294T1/de active Pending
- 1999-02-09 JP JP2000530605A patent/JP4430815B2/ja not_active Expired - Fee Related
- 1999-02-09 DE DE69929417T patent/DE69929417T2/de not_active Expired - Lifetime
- 1999-02-09 EP EP99902859A patent/EP1063294B1/fr not_active Expired - Lifetime
- 1999-02-09 WO PCT/JP1999/000545 patent/WO1999040191A1/fr active IP Right Grant
-
2004
- 2004-02-12 US US10/776,604 patent/US20050003385A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2257029T3 (es) | 2006-07-16 |
EP1063294A1 (fr) | 2000-12-27 |
ATE315645T1 (de) | 2006-02-15 |
DE69929417T2 (de) | 2006-08-03 |
DE69929417D1 (de) | 2006-04-06 |
EP1063294A4 (fr) | 2002-01-16 |
EP1063294B1 (fr) | 2006-01-11 |
AU2299999A (en) | 1999-08-23 |
JP4430815B2 (ja) | 2010-03-10 |
WO1999040191A1 (fr) | 1999-08-12 |
DE1063294T1 (de) | 2003-06-26 |
US6716621B1 (en) | 2004-04-06 |
CA2320220A1 (fr) | 1999-08-12 |
US20050003385A1 (en) | 2005-01-06 |
CA2320220C (fr) | 2011-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1063294T3 (da) | DNA'er eller gener der deltager i Parkinsons sygdom | |
ES2066760T3 (es) | Nucleotidos de alquinilamino. | |
DK1013661T3 (da) | 2'-O,4'-metylen bicyklonukleosid | |
ATE232880T1 (de) | Neue nucleotidanaloga | |
DE69834056D1 (de) | De novo oder "universaler" sequenzierungs-array | |
DE69729122D1 (de) | KüNSTLICHE FEHLHYBRIDISIERUNG | |
IL144374A0 (en) | Method of identifying cytosine methylation patterns in genomic dna samples | |
PT920498E (pt) | Adn regulador transcricional de ef-1x de hamster | |
DE69736840D1 (de) | Synthese von nukleosiden und polynukleotiden | |
DK0960192T3 (da) | Syntetiske polynukleotider | |
CA2195971A1 (fr) | Sondes de detection par hybridation d'acides nucleiques ciblant les acides nucleiques de mycoplasma pneumoniae | |
CY1108240T1 (el) | ΑΠΟΜΟΝΩΜΕΝΑ ΠΟΛΥΝΟΥΚΛΕΟΤΙΔΙΑ ΤΑ ΟΠΟΙΑ ΕΧΟΥΝ ΕΝΑ ΜΕΙΩΜΕΝΟ ΠΕΡΙΕΧΟΜΕΝΟ ΜΟΤΙΒΩΝ 5΄CpG3΄ ΕΠΙΓΕΝΕΤΙΚΟΥ ΕΛΕΓΧΟΥ ΚΑΙ ΟΙ ΧΡΗΣΕΙΣ ΤΟΥΣ | |
ATE386819T1 (de) | Verfahren zur analyse von aflp reaktionsmischungen unter verwendung von primer verlängerungstechniken | |
WO2000063441A3 (fr) | Polymorphismes de nucleotides simples dans des genes mitochondriaux qui segregent avec la maladie d'alzheimer | |
ATE242261T1 (de) | Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen | |
DK1108786T3 (da) | Hidtil ukendt kollektin | |
ATE270331T1 (de) | Rezeptor und dafür kodierendes nukleinsäuremolekül | |
NO995858L (no) | Ny klasse kationiske nukleinsyre-overføringsmidler | |
TR199902434T2 (xx) | Bakteriyel plazmidler. | |
ATE350489T1 (de) | Diagnose von mit humos assoziierten krankheiten | |
DE59914061D1 (de) | Das gen prv-1 und dessen verwendung | |
DE20111754U1 (de) | Leitfähigkeits-Hybridisierung | |
DK1317548T3 (da) | Transglutaminasegenprodukter | |
CY1113694T1 (el) | Πιστοποιηση μιας παραλλαγης dna που συνδυαζεται με υπολακτασια τυπου-ενηλικα | |
WO2003014342A3 (fr) | Identification d'une variante d'adn associee a l'hypolactasie de type adulte |